MedTrace Logo

Italian iTTP Registry

NCT06376786 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2024-07-10

No results posted yet for this study

Summary

ItaliTTP is an observational, prospective, single-arm, national, multicenter, non-pharmacological cohort study aimed at better defining and understanding the natural history, disease severity, and clinical outcomes of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) in Italy.

A minimum of 132 consecutive patients with acute iTTP (first event or relapse) will be enrolled for 3 years, with the possibility of extension, with a follow-up period of 3 years.

Conditions

  • TTP - Thrombotic Thrombocytopenic Purpura

Sponsors & Collaborators

  • Fondazione Luigi Villa

    lead OTHER

Principal Investigators

  • Flora Peyvandi, MD, PhD · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

Eligibility

Min Age
12 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-20
Primary Completion
2030-05-31
Completion
2030-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06376786 on ClinicalTrials.gov